SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : FONR...Patent on Cancer Detection....
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: luis a. garcia who wrote (435)4/5/1997 3:25:00 PM
From: mentz   of 560
 
Luis, I do not know if I truly understand what you are asking, but I will take a stab. Your impression is correct that FONAR sales are outright transactions, transactions that do not necessarily get recorded until sometimes one quarter or two quarters down the road. The recent selling of the Quad 12000 has not been reflected in the stock's quarterly reports as of yet. Yet, the actual cost and expense to land such contracts is usually reflected in the present. Thus, what I am trying to say is, if you look at the quarterly reports, you'll be able to determine costs and expenses without truly seeing a reflection in revenues. Does that make sense? I hope so. As far as, the percentage of take in development costs, I do not know what you mean...elaborate please. If necessary, E-Mail me at dmentzer@hotmail.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News